MEA parenteral nutrition market is expected to display a CAGR of 7.1% in the forthcoming period owing to variables such as increase in premature births, vulnerability to malnutrition, and increasing prevalence of cancers. In addition, existing malnourished children and premature neonates with a specific need for parenteral nutrition propels the market growth in the near future. With the rise in supply of parenteral nutrition, the regions have witnessed a strong decline in the prevalence of chronic disease and malnourishment.
Driving
factors responsible for MEA parenteral nutrition market include decline in
child mortality rate and improved healthcare settings. Rise in improved birth
rate with enhanced nutrition levels is expected to bolster MEA market during
the forecast period. Malnutrition is one of the primary drivers for MEA
parenteral nutrition industry. Secondary drivers include prevalence of chronic
conditions and administration of important nutrients that help in maintaining
energy, strength and hydration level.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/mea-parenteral-nutrition-market/request-sample
Nutrient
type for MEA parenteral nutrition market includes single amino dose acid, trace
elements, vitamins & minerals, carbohydrates, and parenteral lipid
emulsions. Simple dose amino acid dominates the market segment in the forecast
period owing to substantial increase in supply of medical formulations.
Geographical
segmentation for MEA parenteral nutrition market include Saudi Arabia, Kuwait,
Oman, Jordan, Lebanon, and UAE. Saudi Arabia accounted for a significant market
share in 2016followed by Kuwait, Oman, Jordan, and Lebanon. Rise in healthcare
settings, increase in awareness and rise in healthcare expenditure is likely to
support the market growth in MEA regions. Healthcare settings in UAE witnesses
several improvements resulting out of significant investments by local
government.
The
key players in the MEA parenteral nutrition industry includes B. Braun
Melsungen AG; Baxter; Fresenius Kabi AG; Hospira Inc.; Qatar Pharma Factory;
Pharmaceutical Solutions Industry; Kuwait Saudi Pharmaceutical Industries Co.;
Alfa Laboratories; and Well Pharma.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/mea-parenteral-nutrition-market
MEA Parenteral Nutrition Nutrient
Type Outlook (Revenue, USD Million; 2014 - 2025)
• Carbohydrate
• Parenteral Lipid Emulsions
• Single Dose Amino Acid Solutions
• Trace Elements
• Vitamins and Minerals
MEA
Parenteral Nutrition Dosage Form Outlook (Revenue, USD Million; 2014 - 2025)
• Vials
• Ampoules
• Bottles
• Bags
• Multi chambered bags
• Other bags
MEA
Parenteral Nutrition Regional Outlook (Revenue, USD Million; 2014 - 2025)
• Saudi Arabia
• Qatar
• Kuwait
• UAE
• Oman
• Egypt
• Lebanon
• Jordan
Comments
Post a Comment
Let me know what you're interested in